205 related articles for article (PubMed ID: 19387107)
1. Mechanisms of ceramide-mediated neurodegeneration.
Tong M; de la Monte SM
J Alzheimers Dis; 2009; 16(4):705-14. PubMed ID: 19387107
[TBL] [Abstract][Full Text] [Related]
2. Ceramide-mediated insulin resistance and impairment of cognitive-motor functions.
de la Monte SM; Tong M; Nguyen V; Setshedi M; Longato L; Wands JR
J Alzheimers Dis; 2010; 21(3):967-84. PubMed ID: 20693650
[TBL] [Abstract][Full Text] [Related]
3. Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis.
Lyn-Cook LE; Lawton M; Tong M; Silbermann E; Longato L; Jiao P; Mark P; Wands JR; Xu H; de la Monte SM
J Alzheimers Dis; 2009; 16(4):715-29. PubMed ID: 19387108
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of nitrosamine-mediated neurodegeneration: potential relevance to sporadic Alzheimer's disease.
de la Monte SM; Tong M
J Alzheimers Dis; 2009; 17(4):817-25. PubMed ID: 19542621
[TBL] [Abstract][Full Text] [Related]
5. Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease.
Tong M; Neusner A; Longato L; Lawton M; Wands JR; de la Monte SM
J Alzheimers Dis; 2009; 17(4):827-44. PubMed ID: 20387270
[TBL] [Abstract][Full Text] [Related]
6. Triangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewed.
de la Monte SM
J Alzheimers Dis; 2012; 30 Suppl 2(0 2):S231-49. PubMed ID: 22337830
[TBL] [Abstract][Full Text] [Related]
7. Central insulin and insulin-like growth factor-1 signaling: implications for diabetes associated dementia.
Zemva J; Schubert M
Curr Diabetes Rev; 2011 Sep; 7(5):356-66. PubMed ID: 21916834
[TBL] [Abstract][Full Text] [Related]
8. Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus.
Moroz N; Tong M; Longato L; Xu H; de la Monte SM
J Alzheimers Dis; 2008 Sep; 15(1):29-44. PubMed ID: 18780965
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.
de la Monte SM; Longato L; Tong M; Wands JR
Curr Opin Investig Drugs; 2009 Oct; 10(10):1049-60. PubMed ID: 19777393
[TBL] [Abstract][Full Text] [Related]
10. Tobacco Smoke Exposure Impairs Brain Insulin/IGF Signaling: Potential Co-Factor Role in Neurodegeneration.
Deochand C; Tong M; Agarwal AR; Cadenas E; de la Monte SM
J Alzheimers Dis; 2016; 50(2):373-86. PubMed ID: 26682684
[TBL] [Abstract][Full Text] [Related]
11. Ceramide inhibitor myriocin restores insulin/insulin growth factor signaling for liver remodeling in experimental alcohol-related steatohepatitis.
Lizarazo D; Zabala V; Tong M; Longato L; de la Monte SM
J Gastroenterol Hepatol; 2013 Oct; 28(10):1660-8. PubMed ID: 23802886
[TBL] [Abstract][Full Text] [Related]
12. Nitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment.
de la Monte SM; Tong M; Lawton M; Longato L
Mol Neurodegener; 2009 Dec; 4():54. PubMed ID: 20034403
[TBL] [Abstract][Full Text] [Related]
13. The liver-brain axis of alcohol-mediated neurodegeneration: role of toxic lipids.
de la Monte SM; Longato L; Tong M; DeNucci S; Wands JR
Int J Environ Res Public Health; 2009 Jul; 6(7):2055-75. PubMed ID: 19742171
[TBL] [Abstract][Full Text] [Related]
14. Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease.
de la Monte SM; Tong M; Schiano I; Didsbury J
J Alzheimers Dis; 2017; 55(2):849-864. PubMed ID: 27802237
[TBL] [Abstract][Full Text] [Related]
15. Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration.
Tong M; Longato L; de la Monte SM
BMC Endocr Disord; 2010 Mar; 10():4. PubMed ID: 20302640
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-1-dependent maintenance of neuronal metabolism through the phosphatidylinositol 3-kinase-Akt pathway is inhibited by C2-ceramide in CAD cells.
Arboleda G; Huang TJ; Waters C; Verkhratsky A; Fernyhough P; Gibson RM
Eur J Neurosci; 2007 May; 25(10):3030-8. PubMed ID: 17561816
[TBL] [Abstract][Full Text] [Related]
17. Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine.
Rivera EJ; Goldin A; Fulmer N; Tavares R; Wands JR; de la Monte SM
J Alzheimers Dis; 2005 Dec; 8(3):247-68. PubMed ID: 16340083
[TBL] [Abstract][Full Text] [Related]
18. Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.
Lester-Coll N; Rivera EJ; Soscia SJ; Doiron K; Wands JR; de la Monte SM
J Alzheimers Dis; 2006 Mar; 9(1):13-33. PubMed ID: 16627931
[TBL] [Abstract][Full Text] [Related]
19. Role of ceramide-to-dihydroceramide ratios for insulin resistance and non-alcoholic fatty liver disease in humans.
Apostolopoulou M; Gordillo R; Gancheva S; Strassburger K; Herder C; Esposito I; Schlensak M; Scherer PE; Roden M
BMJ Open Diabetes Res Care; 2020 Nov; 8(2):. PubMed ID: 33219119
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance and Alzheimer's disease.
de la Monte SM
BMB Rep; 2009 Aug; 42(8):475-81. PubMed ID: 19712582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
